[ad_1]
This article is over a month old and may contain outdated advice from authorities regarding coronary heart disease.
Stay up to date on the NRK overview or on the FHI website.
This week, the coronary vaccine was developed by German BioNTech, with funding from the American company Pfizer, and was urgently approved in the UK. On Sunday, the first delivery of the Pfizer vaccine arrived at Croydon University Hospital in south London.
Images distributed by the National Health Service show that the vaccine was delivered in specially adapted boxes. Pfizer has previously said that the vaccine should be stored very cold, between minus 70 and 80 degrees.
According to Sky News, Croydon Hospital will be the first in the world to receive the Pfizer vaccine.
– This is so exciting. This is an important opportunity, says Louise Coghlan, who shares the job as the hospital’s chief pharmacist, according to Reuters.
800,000 doses first
The UK is scheduled to start vaccinating from Tuesday this week. British health authorities have said that people over 80, frontline health workers, and nursing home nurses and staff should take priority.
The vaccine will initially be available in some hospitals, before being sent to doctors’ offices, according to British authorities.
This week, however, the UK will only have access to around 800,000 doses. The first doses were shipped from Belgium. They will be stored safely and are subject to the necessary quality controls, according to the British health authorities.
A technician places the first doses of the Pfizer vaccine in a freezer at minus 80 degrees.
Photo: Gareth Fuller / AP
Has ordered 40 million doses
The UK has ordered a total of 40 million doses. As each person must receive the vaccine in two rounds, it is enough to vaccinate 20 of the approximately 67 million inhabitants of the country.
However, in early December, Pfizer announced that they could only deliver about half of the vaccine doses they expected before the New Year.
The UK urgently approved the Pfizer vaccine for emergency use last week, making it a small step forward in the queue to begin mass vaccination.
Prime Minister Boris Johnson said earlier this week that he hopes the vaccine can help get life back to normal.
– It’s the protection of vaccines that will ultimately bring us back to life and get the economy working again, says Johnson.
British health authorities stated earlier this week that the vaccine is completely safe.
– We have not taken shortcuts. Our researchers and doctors have been working around the clock to implement it as quickly as possible, says June Raine, director of the British Medicines Agency (MHRA).
Biontech, Fosun Pharma and Pfizer
The German pharmaceutical company BioNTech reports that its coronary vaccine has been shown to be 95 percent effective. The UK will start vaccinating in December.
The BNT162b2 vaccine relies on your body’s system for building things. The vaccine is just building instructions for the cells. The instructions are based on the same codes that cells use all the time for this purpose. These are called mRNAs or “messenger ribonucleic acids.”
What happens is the following:
The vaccine is injected into your body. The information from the vaccine reaches the machines in the cells that make proteins. These machines build copies of the so-called “spike protein” of the coronavirus. These proteins are secreted by cells and detected by the immune system. The immune system reacts in the same way as if the real coronavirus had entered the body. Antibodies are produced and the immune system remembers that the coronavirus is something else to react to.
You have been vaccinated.
May be approved by the EU this Christmas
The vaccine has not yet been approved by the EU Medicines Agency, which will process the case this Christmas. When it is, it is also approved for use in Norway. The Pfizer vaccine will also be pending approval in the US in the middle of the month.
Steinar Madsen, medical director of the Norwegian Medicines Agency, said earlier this week that he was confident of the UK news. Madsen called it “a good sign” considering the rest of the approval process.
– If this has any direct meaning, I probably don’t think so, but of course it is very interesting that the British acted so fast, Madsen told NRK.
According to the researchers, the vaccine should be 95 percent effective. So far no serious side effects have been reported. Madsen has previously noted the importance of having good tools to report any side effects, as the vaccine is used on a large scale.
The Russian authorities were the first to issue the water vaccination to selected groups, with their own vaccine, “Sputnik V.”
